Insmed, Inc. (INSM): Price and Financial Metrics

Insmed, Inc. (INSM): $64.71

0.87 (-1.33%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add INSM to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#113 of 348

in industry

INSM Price/Volume Stats

Current price $64.71 52-week high $66.98
Prev. close $65.58 52-week low $19.68
Day low $63.80 Volume 2,365,900
Day high $66.98 Avg. volume 2,501,254
50-day MA $36.85 Dividend yield N/A
200-day MA $29.37 Market Cap 9.62B

INSM Stock Price Chart Interactive Chart >


Insmed, Inc. (INSM) Company Bio


Insmed Incorporated is a biopharmaceutical company focused on developing targeted inhaled therapies for patients suffering from rare lung diseases. The company was founded in 1999 and is based in Bridgewater, New Jersey.


INSM Latest News Stream


Event/Time News Detail
Loading, please wait...

INSM Latest Social Stream


Loading social stream, please wait...

View Full INSM Social Stream

Latest INSM News From Around the Web

Below are the latest news stories about INSMED INC that investors may wish to consider to help them evaluate INSM as an investment opportunity.

Insmed Inc Chief Medical Officer Martina Flammer Sells 28,310 Shares

On December 22, 2023, Martina Flammer, the Chief Medical Officer of Insmed Incorporated (NASDAQ:INSM), sold 28,310 shares of the company's stock, according to a recent SEC Filing.

Yahoo | December 23, 2023

Investors ignore increasing losses at Insmed (NASDAQ:INSM) as stock jumps 9.0% this past week

If you want to compound wealth in the stock market, you can do so by buying an index fund. But in our experience...

Yahoo | December 7, 2023

12 Most Promising Stocks to Buy According to Hedge Funds

In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Promising Stocks to Buy According to Hedge Funds. Analysts and financial institutions are starting to release their 2024 market outlook reports and predictions and you […]

Yahoo | December 5, 2023

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to 14 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.

Yahoo | December 5, 2023

Insmed To Present at the Nasdaq 49th Investor Conference

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the Nasdaq 49th Investor Conference in London on Wednesday, December 6, 2023, at 8:30 a.m. ET/1:30 p.m. GMT.

Yahoo | November 29, 2023

Read More 'INSM' Stories Here

INSM Price Returns

1-mo 163.80%
3-mo 144.84%
6-mo 115.41%
1-year 212.76%
3-year 124.92%
5-year 141.82%
YTD 108.81%
2023 55.11%
2022 -26.65%
2021 -18.17%
2020 39.41%
2019 82.01%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!